technology
Science Corporation implants vision-restoring chip in first patient with Stargardt disease
13 Ekim 2026TechCrunch
- Science Corporation has successfully implanted its vision-restoring chip in a patient suffering from Stargardt disease, marking a significant milestone in medical technology.
- Science Corporation has successfully implanted its vision-restoring chip in its first patient suffering from Stargardt disease. Max Hodak, co-founder of Neuralink, discussed this groundbreaking achievement during the TechCrunch Disrupt event.
- The chip is part of a broader initiative aimed at developing advanced brain-computer interfaces (BCI). This milestone represents a significant step forward in the treatment of vision impairments caused by genetic conditions.
- Stargardt disease is a genetic condition that leads to progressive vision loss, affecting thousands of individuals worldwide. The development of a vision-restoring chip represents a significant innovation in the field of ophthalmology and neuroscience, potentially offering new hope to those affected by similar condi…
- The implantation of the vision-restoring chip marks a pivotal moment in the intersection of biotechnology and neural engineering. As companies like Science Corporation push the boundaries of what is possible with BCIs, the implications for patients with degenerative eye diseases could be profound.
NewsAI özeti
This article is for informational purposes only and does not constitute medical advice. Readers should consult healthcare professionals for medical concerns.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.